The best-characterised hidden antigen of Haemonchus contortus, called H11, is a 110 kDa gut membrane glycoprotein (Smith et al., 1993) belonging to the M1 aminopeptidase family. Native H11, isolated from adult H. contortus, had been evaluated in numerous vaccine experiments in sheep of different breeds, including very young lambs, and shown to induce high levels of antibody-mediated protection, reflected in (on average) a >90% reduction in faecal egg counts (FECs) and > 75% reduction in worm burdens (reviewed by Newton and Munn, 1999; Newton and Meeusen, 2003; Knox, 2011). Molecular characterisation showed that H11 is a microsomal aminopeptidase (Graham et al., 1993; Smith et al., 1997), believed to be involved in the degradation of small peptides from dietary proteins (Munn and Munn, 2002). At the time, it was proposed that protection was achieved via antibody-induced disruption of nutrient absorption by the worm.
Originally, three isoforms of H11 (designated H11-1, -2 and -3; GenBank accession nos. AJ249941, AJ249942 and AJ311316, respectively), sharing ~ 61-70% amino acid sequence identity, were reported (Graham et al., 1993; Hederer et al. 2001, direct submission to GenBank). Subsequently, two other isoforms (H11-4 and -5) had been sequenced and deposited in the GenBank database (accession nos. FJ481146 and X94187) (Smith et al., 1997; Zhou et al., 2010). Although vaccination success was achieved using purified, native H11, and cDNA clones were patented
Click here to unlock this and over one million essaysGet Access
The history of vaccinations begin with Edward Jenner, the country doctor from Gloucestershire who found, growing on cows, a nearly harmless virus the protected people from smallpox. Jenner’s vaccine was safer, more reliable, and more durable than variolation, and it is still the only vaccine to have eliminated its reason for being-in 1980, when the World Health Organization (WHO) declared the disease extinct. For nearly a century and a half, smallpox was the only vaccine routinely administered, and it saved millions of lives . But the controversy that marked the return of the vaccine, amid bioterrorism hysteria in 2002, was only the latest twist in the remarkable, mysterious life of vaccines.
Through the understanding of infectious diseases, researchers have been able to create several types of vaccines to help prevent a variety of life-threatening illnesses. Scientists develop immunizations using different techniques to treat diseases. These types include: live, killed, toxoids, subunit, and conjugate vaccines. Vaccinations that are the live type use a specific process which when administered will expose the patient to the actual disease, but in a much
Edward Jenner and the Discovery of Vaccines Edward Jenner (1749-1823) trained in London, under John Hunter, and was an army surgeon for a period of time. After that, he spent his whole career as a country doctor in his home county, Gloucestershire (West of England). His research was based on careful case studies and clinical observation more than a hundred years before scientists could explain what viruses and diseases actually were. His innovative new method was successful to such an extent that by 1840 the British government had banned alternative preventive treatments against smallpox. [IMAGE]
Hilleman’s career life was dedicated to the studying and finding relationships amongst the different diseases causing agents or viruses. As such, the presentation of the finite information about the microorganisms and their associated characteristics opens up the ground for an increased interest in learning how these viruses work to adapt or overcome the body immunity (Offit, 2007). Moreover, through the demonstrations of some of the adaptive features of viruses such as the mutations or change in the gene constitution, Hilleman has illustrated how the process of establishing the specific vaccines for each disease requires comprehensive knowledge and research of the peculiar characteristics of each virus. These elements depicted in Hilleman’s study form the tenets of microbiology and the different disciplines related to subjects such as virology or the study of bacteria. Henceforth, by reading the book, my understanding of the elements of microbiology and the processes of virus control has been emphasized (Offit, 2007). Additionally, the evaluation of the treatment and prevention procedures for some of the common diseases, especially amongst children, has motivated my interest to research and undertake more in operations surrounding vaccinations and control of disease
In the book, “Survival of the Sickest”, Sharon Moalem forms the basis of how vaccine originated to become a way of combatting the most dangerous diseases in the world. It began with a discovery from a man named Edward Jenner, a doctor from Gloucestershire county in England, where he began to understand a strange pattern when people who were immune to cowpox were struggling with smallpox and vice-versa. He started to test his findings through a small experiment where he injected cow pox into a group of young children and he was surprised to see that their bodies built immunity towards smallpox and supported his findings on the bizarre immunity of people towards either the smallpox or the cowpox but not to both. The rest of the chapter explains complex concepts
Six different batches of recombinant HVT-H5 avian influenza vaccines obtained from office of receiving samples in central laboratory for evaluation of veterinary biologics (CLEVB), Abbasia.
Mandatory vaccination continues to be a contentious subject in the United States, even though extensive evidence proves inoculation prevents certain diseases. According to A. Plotkin & L. Plotkin (2011), the evolution of the first vaccine commenced in the 1700’s when a physician named Edwards Jenner discovered that cowpox protected individuals from one of the deadliest diseases termed smallpox. The precise virus Jenner used is unclear; however, it was espoused in the extermination of smallpox worldwide. The researchers further explained, the unearthing of the subsequent vaccine known as chicken cholera occurred approximately 80 years later by Louise Pasteur. Ever since, copious vaccines such as rabies, yellow fever, varicella, pneumococcal, mumps and recently HPV have been introduced.
Jenner’s vaccine was so successful that the World Health Organization declared the word “entirely eradicated” of human smallpox on December 9, 1979 (Spier, 2015). As a consequence of this monumental success and other successes like it, people forget how deadly diseases like this can be and fail to attribute their lack of a crippling disease to vaccinations. Other diseases that have been considered eliminated in a similar manner to smallpox are: diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, hepatitis A & B, yellow fever (Spier, 2015).
Dr. Diemert and Dr. Bethony from George Washington University are leaders of the only team in the world doing research on a hookworm vaccination. They have developed two different types of vaccines, one of which were used in the study above. These scientists had injected the 10 volunteers with Necator americanus Aspartic Protease-1 (Na-APR-1) and were testing its effectiveness in preventing hookworm disease. The Na-ARP-1 vaccine is designed to target two proteins involved in an adult worm’s blood digestion, which will block the blood digestion pathway in the worm, causing the worms to starve (Ingeno 2015). This clinical trial is still ongoing so they have not yet released the results, however the article above described Phase 1 of this trial. The objective of Phase 1 was to determine the optimal number of worms that needed to be placed in the host in order to get the statistical power to do the vaccine test (Svrluga 2015). Phase 1 volunteers were inoculated with 25 hookworms each, so the next step of this study is to increase the number of hookworms to 50, then 75 hookworms if it all goes well. Again, this is still an ongoing study so results have not yet been released for this study, only the methods and description of the
Moreover, antigens coupled to the surface of liposomes consisting of unsaturated fatty acids have also been reported to be pinocytosed by APCs, loaded onto the class I MHC processing pathway, and presented to both CD4+ and CD8+ T cells . Thus, adjuvant-coupled antigens are anticipated to be appropriate for the development of vaccines that induce humoral and cellular immunity [23, 24]. The T-cell dependent manner in which conjugate vaccines have been described to work could significantly boost immunogenicity compared to unconjugated antigens [25-28].
Background: Haemophilus influenzae is a normal flora colonizing the mucosa of the upper respiratory tract that can cause infections in the respiratory tract. Protein E (PE) is a highly conserved 18 kDa surface lipoprotein which is found in both nontypeable H. influenzae (NTHi) and typeable Haemophilus influenzae. Among typeable Haemophilus influenzae, H. influenzae type b (Hib) has been recognized as the most virulent type, and it causes meningitis infection in children younger than 2 years. The Hib capsular polysaccharide (Polyribosyl ribitolphosphate) (PRP), is used as an important candidate in the Hib vaccines. The PRP in children under 2 years old is not protective. Accordingly in this study, PE of NTHi, that is a major part of outer membrane, was selected to be applied with PRP.
In these days of modern medicine, most children are vaccinated early in life for diseases such as rubella, measles, and tetanus. Vaccines have been perfected to shield and protect our body from seriously life threatening diseases that could have the potential to wipe out large populations. Most of America and a lot of western countries see vaccines as beneficial and a common necessity for their children and themselves. However, this view has not always been accepted. In fact, vaccines were only first widely considered to be helpful for diseases when a man named Louis Pasteur began experimenting with rabies. We will start our journey of microbiological history with the discovery of anthrax and move forward through the creation of Pasteur’s rabies vaccine.
Old world monkeys and chimpanzees can be experimentally infected, and humans are the natural hosts for poliovirus, because these species have suitable environments and receptors for the survival of poliovirus, but other species such as mice do not have suitable environments for poliovirus unless the mice have been experimentally altered to express CD155 (Racaniello, 2005). Some strains of the poliovirus have been able to replicate in mice due to a process of adaptation, and some strains of the virus are naturally virulent in the mice (Racaniello, 2005). Scientists were able to substitute a six amino acid sequence of the P1/Mahoney strain, which is in the VP1 capsid protein and located near the CD155 binding site, with the corresponding sequence in P2/Lansing strain (Racaniello, 2005). This caused the mice to have neurovirulence to the poliovirus (Racaniello, 2005).
Our current society is surrounded by the debatable usage of vaccines and its importance around the world. Since the introduction of immunizations, many diseases have been decreased and even eradicated from humanity. Even though this is true, serious side effects along with lifelong illnesses follow the temporary cure of viruses. A vaccine is a substance that delivers immunity against viruses and is used to stimulate the construction of antibodies. Vaccines are prepared from the disease itself treated to perform as an antigen without inducing the disease (Vaccines). These inoculations are used worldwide and various unknown infections have been speculated as the originations for them. Vaccines were originated as an alternative to cure viruses among people but the harmful symptoms, unknown links to incurable
Another two-component therapeutic glycopeptide vaccine developed by Dr. Li’s group contained the MUC1 tandem repeat sequence covalently attached to BSA or different tetanus toxoid derived T-cell peptide epitopes.159 In this study, the MUC1 tandem repeat glycopeptide sequence HGVTSAPDTRPAPGSTAPPA that was decorated with various combination of T-,Tn- and STn-antigen, was coupled to three different universal T-helper cell epitope peptides, P2 ( TT830–843- QYIKANSKFIGITE), P4 (TT1273–1284- GQIGNDPNRDIL), and P30 (TT947–967-FNNFTVSFWLRVPKVSASHLE) and to BSA (Figure 1.12). It was found that the vaccine